|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | CONSORT 2010说明与详述:报告平行对照随机临床试验指南的更新显示文摘大量证据显示随机对照临床试验(randomised controlled trial,RCT)的报告质量不理想。报告不透明,则读者既不能评判试验结果是否真实可靠,也不能从中提取可用于系统综述的信息。最近的方法学分析表明,报告不充分和设计不合理与对治疗效果产生评价偏倚有关。这种系统误差对RCT损害严重,而RCT正是以其能减少或避免偏倚而被视为评价干预措施的金标准。为了提高RCT的报告质量,一个由专家和编辑组成的工作组制定了临床试验报告的统一标准(Consolidated Standards of Reporting Trials,CONSORT)声明。CONSORT声明于1996年首次发表,并于2001年更新。声明由对照检查清单和流程图组成,供作者在报告RCT时使用。许多核心医学期刊和主要国际性编辑组织都已认可CONSORT声明。该声明促进了对RCT的严格评价和解释。2001年,在对CONSORT进行修订时,人们就已经清楚地认识到,解释和说明制定CONSORT声明的原理,有助于研究人员等撰写或评价临床试验报告。一篇CONSORT说明与详述文章于2001年同2001版CONSORT声明一起发表。2007年1月的专家会议之后,对CONSORT声明作了进一步修订并已发表,即'CONSORT2010声明'。这次更新对原版对照检查清单作了文字上的修改,使其更为明晰,并收入了与一些新近才认识到的主题相关的建议,如选择性报告结局产生的偏倚。说明与详述文件旨在加强人们对CONSORT声明的理解、应用和传播,这次也作了大量修订,对每一项新增或更新的清单条目的含义和增改理由进行了解释,提供了优秀的报告实例,还尽可能地提供了相关的经验性研究的参考文献。文中收入了若干流程图实例。'CONSORT2010声明'、其说明与详述文件,以及相关网站(www.consort-statement.org),对于改进随机临床试验报告必将有所裨益。 | David Moher Sally Hopewell Kenneth F Schulz Victor Montori Peter C Gφtzsche P J Devereaux Diana Elbourne Matthias Egger Douglas G Altman 周庆辉 卞兆祥 刘建平 | 2010 | 中西医结合学报2010，8，8： | 318 |
| 2 | GRADE指南:Ⅴ.证据质量评价--发表偏倚显示文摘GRADE方法中,随机试验起评即为高质量证据,观察性研究起评即为低质量证据;但若证据本身存在高发表偏倚风险,则两者证据质量级别都应降低。即使最佳证据汇总表纳入的各项研究仅有低发表偏倚风险,发表偏倚仍会极大高估效应值。当可得证据来自小样本研究、且多数由厂商资助时,作者应怀疑存在发表偏倚。若干基于检验数据类型的方法可用于评价发表偏倚,其中最常用的为漏斗图,但这些方法都有较大局限。发表偏倚可能较常见,必须特别关注早期结果、对样本量与事件数都很小的早期试验结果尤需小心。 | Gordon H.Guyatt Andrew D.Oxman Victor Montori Gunn Vist Regina Kunz Jan Brozek Pablo Alonso-Coello Ben Djulbegovic David Atkins Yngve Falck-Ytter John W.Williams Jr. Joerg Meerpohl Susan L.Norris Elie A.Akl Holger J.Schünemann 代表GRADE工作组 李幼平 王莉 钟大可 蒋兰慧 | 2011 | 中国循证医学杂志2011，11，12： | 71 |
| 3 | GRADE指南:Ⅳ.证据质量分级--研究的局限性(偏倚风险)显示文摘在GRADE方法中,若多数相关证据来自高偏倚风险的研究,则起初被定为高质量证据的随机试验和低质量证据的观察性研究均有可能被降低质量等级。随机试验已确定的局限性包括:未进行分配隐藏、未实施盲法、未报告失访情况及未恰当考虑意向性治疗原则。最近提出的局限性包括:因明显获益而早期终止试验和基于结果选择性报告结局。观察性研究的主要局限性包括使用不合适的对照及未能充分调整预后的不平衡。偏倚风险可因不同结果而异(如全死因死亡率的失访远少于生命质量的失访),许多系统评价都容易忽略这一点。在决定是否因偏倚风险而降低质量等级时,不管是随机试验还是观察性研究,作者不应采用对各个研究取平均值的方法。相反,对任何单个结果,当同时存在高、低偏倚风险的研究时,则应考虑只纳入较低偏倚风险的研究。 | Gordon H.Guyatt Andrew D.Oxman Gunn Vist Regina Kunz Jan Brozek Pablo Alonso-Coello Victor Montori Elie A.Akl Ben Djulbegovic Yngve Falck-Ytter Susan L.Norris John W.Williams Jr. David Atkins Joerg Meerpohl Holger J.Schünemann GRADE工作组 李幼平 杨晓妍 李鸿浩 李玲 | 2011 | 中国循证医学杂志2011，11，4： | 58 |
| 4 | 颈动脉粥样硬化疾病的处理美国血管外科学会临床实践指南显示文摘美国血管外科学会(SVS)任命了一个专家委员会制定颈动脉狭窄处理的循证临床指南。在制定临床实践推荐意见过程中,该委员会使用系统评价对当前最件的证据进行了总结,采用GRADE标准对推荐意见的强度(强烈推荐为GRADEI级,一般推荐为GRADEⅡ级)和证据的质量(高、中、低和极低)进行了分级。对于轻度颈动脉狭窄患者(有症状患者狭窄程度〈50%和无症状患者狭窄程度〈60%),推荐进行最佳的内科治疗而非血管重建术(I级推荐,高质量证据)。对于有症状中到重度狭窄患者(狭窄程度≥50%),推荐行颈动脉内膜切除术(CEA)+最佳的内科治疗(I级推荐,高质量证据)。对于围手术期风险高的有症状巾到重度狭窄患者(狭窄程度≥50%),建议采用颈动脉支架置入术作为其替代治疗手段(Ⅱ级推荐,低质量证据)。对于中到重度狭窄的无症状患者(狭窄程度≥60%),只要围手术期风险较低,就推荐行CEA+内科治疗(I级推荐,高质量证据)。对于中到重度狭窄的尢症状患者(狭窄稗度≥60%),不推荐行颈动脉支架置入术(I级推荐,低质量证据)。颈动脉狭窄≥80%但存在CEA高危解剖学风险的患者可能是一个例外。 | Robert W. Hobson, Ⅱ William C. Mackey Enrico Ascher M. Hassan Murad Keith D. Calligaro Anthony J. Comerota Victor M. Montori Mark K. Eskandari Douglas W. Massop Ruth L. Bush Brajesh K. Lal Bruce A. Perler 刘德志(译) 徐格林(译) 刘新峰(译) | 2008 | 国际脑血管病杂志2008，16，12： | 35 |
| 5 | GRADE指南:Ⅸ.证据质量升级显示文摘证据质量升级的最常见原因是效应量大。当方法学严谨的观察性研究表明风险至少降低或增加2倍时,GRADE建议考虑将证据质量升高1级;当风险至少降低或增加5倍时,考虑将证据质量升高2级。当存在剂量-反应关系,或所有合理的混杂、偏倚会降低明显的治疗效应,或混杂、偏倚使得结果无效为假效应时,系统评价作者和指南制定者也可考虑升高证据质量。其他考虑因素包括起效迅速、潜在的疾病(状态)趋势以及间接证据。 | Gordon H.Guyatt Andrew D.Oxman Shahnaz Sultan Paul Glasziou Elie A.Akl Pablo Alonso-Coello David Atkins Regina Kunz Jan Brozek Victor Montori Roman Jaeschke David Rind Philipp Dahm Joerg Meerpohl Gunn Vist Elise Berliner Susan Norris Yngve Falck-Ytter M.Hassan Murad Holger J.Schünemann 代表GRADE工作组 李幼平 杨晓妍 李玲 王应强 | 2011 | 中国循证医学杂志2011，11，12： | 22 |
| 6 | 诊断性试验和策略的证据质量和推荐强度的分级显示文摘GRADE系统能对诊断性试验或策略的证据质量和推荐强度进行分级。本文旨在阐释在此过程中如何考虑患者的重要结局, | Holger J Schünemann Andrew D Oxman Jan Brozek Paul Glasziou Roman Jaeschke Gunn E Vist John W Williams Jr Regina Kunz Jonathan Craig Victor M Montori Patrick Bossuyt Gordon H Guyatt 李晓 黄程 陈耀龙 李幼平 | 2009 | 中国循证医学杂志2009，9，5： | 7 |
| 7 | Preferences and attitudes of young Chinese clinicians about using a shared decision making tools for communicating cardiovascular risk显示文摘Objective: This study assesses the attitudes and preferences of Chinese clinicians toward their involvement in shared decision making (SDM). Methods: From May 2014 to May 2015, 200 Chinese clinicians from two hospitals were enrolled to complete a survey on their attitude towards SDM. We conducted the survey via face-to-face interviews before and after an educational intervention on SDM among young Chinese clinicians. The clinicians were asked to give the extent of agreement to SDM. They also gave the extent of difficulty in using decision aids (DAs) during the SDM process. The variation in the range of responses to each question before and after the SDM intervention was recorded. The frequency of changed responses was analyzed by using JMP 6.0 software. Data were statistically analyzed using Chi-square and Mann—Whitney U tests, as appropriate to the data type. Multiple logistic regressions were used to test for those factors significantly and independently associated with preference for an approach for each scenario. Results: Of the 200 young Chinese clinicians sampled, 59.0% indicated a preference for SDM and a desire to participate in SDM before receiving education or seeing the DA, and this number increased to 69.0% after seeing the DA with the sample video of the SDM process on Statin Choice. However, 28.5% of the respondents still reported that, in their current practice, they make clinical decisions on behalf of their patients. The clinicians who denied a desire to use the DA stated that the main barriers to implement SDM or DA use in China are lack of time and knowledge of SDM. | Rong-Chong Huang Xian-Tao Song Dong-Feng Zhang Jia-Ying Xu Kasey R. Boehmer Aaron A. Leppin Michael R. Gionfriddo Henry H. Ting Victor M. Montori | 2019 | Chronic Diseases and Translational Medicine2019，5，2： | 4 |
| 8 | A systematic review and meta-analysis of the treatments of varicose veins显示文摘 | M. Hassan Murad Fernando Coto-Yglesias Magaly Zumaeta-Garcia Mohamed B. Elamin Murali K. Duggirala Patricia J. Erwin Victor M. Montori Peter Gloviczki | 2011 | Journal of Vascular Surgery2011，，5： | 3 |
| 9 | Diagnosis and Treatment of Hyperprolactinemia: An Endocrine Society Clinical Practice Guideline显示文摘 | Shlomo Melmed Felipe F. Casanueva Andrew R. Hoffman David L. Kleinberg Victor M. Montori Janet A. Schlechte John A. H. Wass | 2011 | Clinical Endocrinology and Metabolism2011，，2： | 2 |
| 10 | Metabolic Syndrome and Risk of Incident Cardiovascular Events and Death显示文摘 | Apoor S. Gami Brandi J. Witt Daniel E. Howard Patricia J. Erwin Lisa A. Gami Virend K. Somers Victor M. Montori | 2007 | Journal of the American College of Cardiology2007，，4： | 2 |
| 11 | Evaluation and Management of Adult Hypoglycemic Disorders: An Endocrine Society Clinical Practice Guideline显示文摘 | Philip E. Cryer Lloyd Axelrod Ashley B. Grossman Simon R. Heller Victor M. Montori Elizabeth R. Seaquist F John Service | 2009 | The Journal of Clinical Endocrinology & Metabolism2009，，3： | 2 |
| 12 | The effect of left subclavian artery coverage on morbidity and mortality in patients undergoing endovascular thoracic aortic interventions: A systematic review and meta-analysis显示文摘 | Adnan Z. Rizvi M. Hassan Murad Ronald M. Fairman Patricia J. Erwin Victor M. Montori | 2009 | Journal of Vascular Surgery2009，，5： | 1 |
| 13 | Adverse Effects of the Common Treatments for Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis显示文摘 | Juan Pablo Domecq Gabriela Prutsky Rebecca J. Mullan Vishnu Sundaresh Amy T. Wang Patricia J. Erwin Corrine Welt David Ehrmann Victor M. Montori Mohammad Hassan Murad | 2013 | The Journal of Clinical Endocrinology & Metabolism2013，，12： | 1 |
| 14 | Behavioral Interventions to Prevent Childhood Obesity: A Systematic Review and Metaanalyses of Randomized Trials显示文摘 | Celia C. Kamath Kristin S. Vickers Angela Ehrlich Lauren McGovern Jonathan Johnson Vibha Singhal Remberto Paulo Allison Hettinger Patricia J. Erwin Victor M. Montori | 2008 | The Journal of Clinical Endocrinology & Metabolism2008，，： | 1 |
| 15 | What is evidence-based medicine?显示文摘 | Victor M Montori Gordon H Guyatt | 2002 | Endocrinology and Metabolism Clinics of North America2002，，3： | 1 |
| 16 | Continuous Glucose Monitoring: An Endocrine Society Clinical Practice Guideline显示文摘 | David C. Klonoff Bruce Buckingham Jens S. Christiansen Victor M. Montori William V. Tamborlane Robert A. Vigersky Howard Wolpert | 2011 | The Journal of Clinical Endocrinology & Metabolism2011，，10： | 1 |
| 17 | Lifestyle Modification Programs in Polycystic Ovary Syndrome: Systematic Review and Meta-Analysis显示文摘 | Juan Pablo Domecq Gabriela Prutsky Rebecca J. Mullan Ahmad Hazem Vishnu Sundaresh Mohammed B. Elamin Olivia J. Phung Amy Wang Kathleen Hoeger Renato Pasquali Patricia Erwin Amy Bodde Victor M. Montori M. Hassan Murad | 2013 | The Journal of Clinical Endocrinology & Metabolism2013，，12： | 1 |
| 18 | Vitamin D and Cardiovascular Outcomes: A Systematic Review and Meta-Analysis显示文摘 | Mohamed B. Elamin Nisrin O. Abu Elnour Khalid B. Elamin Mitra M. Fatourechi Aziz A. Alkatib Jaime P. Almandoz Hau Liu Melanie A. Lane Rebecca J. Mullan Ahmad Hazem Patricia J. Erwin Donald D. Hensrud Mohammad Hassan Murad Victor M. Montori | 2011 | The Journal of Clinical Endocrinology & Metabolism2011，，7： | 1 |
| 19 | The Diagnosis of Cushing?s Syndrome: An Endocrine Society Clinical Practice Guideline显示文摘 | Lynnette K. Nieman Beverly M. K. Biller James W. Findling John Newell-Price Martin O. Savage Paul M. Stewart Victor M. Montori | 2008 | The Journal of Clinical Endocrinology & Metabolism2008，，5： | 1 |
| 20 | A systematic review and meta-analysis of the treatments of varicose veins显示文摘 | M. Hassan Murad Fernando Coto-Yglesias Magaly Zumaeta-Garcia Mohamed B. Elamin Murali K. Duggirala Patricia J. Erwin Victor M. Montori Peter Gloviczki | 2011 | Journal of Vascular Surgery2011，，5： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员